Global Pain Relief Therapy Market, By Products (Prescription based products, OTC-based products {Pharmaceuticals, Medical Devices), Mode of Purchase (Over-The-Counter, Prescribed), Application (Musculoskeletal Disorder, Sport Medicine, Post-operative, Post-trauma, Physical Therapy), End-User (Hospitals, Clinics, Ambulatory Centers, Physiotherapy Centers, Homecare Settings), – Industry Trends and Forecast to 2029
Market Analysis and Size
Pain is an upsetting sensory and emotional sensation caused by tissue damage or disease. Various disorders, such as multiple sclerosis, osteoarthritis, stomach ulcers, chronic arthritis, fibromyalgia, diabetic neuropathy, and cancer, may also cause discomfort. The duration of pain varies from acute pain in the short term to chronic pain in the long term. Acute pain can be mild and last only a few seconds, or it can last weeks or months. Chronic pain is caused by degenerative bone and joint disease, nerve damage, or injury. To manage pain caused by inflammation in response to tissue damage, chemical agents/pathogens (nociceptive pain), or nerve damage, a variety of drugs and equipment are used (neuropathic pain). The majority of drugs work by binding to protein targets on cell membranes and influencing biochemical processes.
Data Bridge Market Research analyses that the pain relief therapy market is expected to reach the value of USD 92.34 billion by the year 2029, at a CAGR of 12.75% during the forecast period. The increasing number of clinical trials will aid in the expansion of the pain relief therapy market.
Market Definition
Pain is multifaceted, and its treatment comes in a variety of forms. Natural pain can occur as a result of natural lifestyle changes, and pain can occur for a variety of reasons, such as injuries or chronic diseases. Pain is an intensely unpleasant sensory of the nervous system's mechanism for alerting the brain that action must be taken as soon as possible to protect the body from a variety of symptoms.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2010)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Products (Prescription based products, OTC-based products {Pharmaceuticals, Medical Devices), Mode of Purchase (Over-The-Counter, Prescribed), Application (Musculoskeletal Disorder, Sport Medicine, Post-operative, Post-trauma, Physical Therapy), End-User (Hospitals, Clinics, Ambulatory Centers, Physiotherapy Centers, Homecare Settings)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Medtronic PLC (Ireland), Boston Scientific (US), Abbott (US), Becton Dickinson and Company (US), Baxter International (US), B. Braun Melsungen AG (Germany), Stryker (US), Smiths Medical (US), Moog Inc. (US), Avanos Medical, Inc. (US), Nipro Corporation (Japan), Atricure (US), Nevro Corp. (US, Micrel Medical Devices SA (Greece), InfuTronix Solutions LLC (US), Teleflex, Inc. (US), Mindray Medical International Limited (China), Virchow Biotech (India),
|
|
|
|
|
Opportunities
|
|
|
|
|
|
|
|
Pain Relief Therapy Market Dynamics
Drivers
- The rise in the awareness by the population
Factors such as rising concern about the potential consequences of long-term use of pain treatment drugs, involving compact efficiency, the risk of addiction, and side effects, are expected to drive the growth of the pain relief therapy market in the region during the forecast period.
The increase in the collaborations from market players
The developments of large untapped markets, as well as drug advancement in emerging economies, are expected to drive the growth of the pain relief therapy market even further.
- Government investments for healthcare interoperability
The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the pain relief therapy market.
.Restraints/Challenges
Skin irritation, burning sensations, and allergic reactions caused by overuse of pain relievers are expected to impede the growth of the pain relief therapy market in the coming years..
This pain relief therapy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pain relief therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Pain Relief Therapy Market
The pain relief therapy market lost business, and the trend is expected to continue until late December 2020. Unfavorable changes in regulations and guidelines are stifling this industry's growth. Cancer patients are at a higher risk of COVID-19 infection than healthy adults, according to major regulatory authorities around the world (including the CDC, WHO, MHRA, TGA, and EMA). As a result, screening, diagnostic exams, and surgical procedures are severely limited or postponed in hospitals and cancer treatment centres. This is expected to cause disruptions in the market for pain management devices. Because of the aforementioned factors, caregivers and hospitals can expect delays in elective surgeries, screening procedures, and neurostimulation procedures.
.Recent Development
- Medtronic introduced Efficio, a cloud-based data management software for use with the SynchroMed II intrathecal drug delivery system, in January 2020. This enables clinicians to manage their targeted drug delivery pump practises more efficiently when treating patients with chronic pain, cancer, and severe spasticity.
- Abbott will launch the IonicRF Generator, a minimally invasive device that uses heat to target specific nerves for chronic pain management, in November 2020.
- Boston Scientific purchased Vertiflex, Inc. (US) in June 2019, a privately held developer of the Superion Indirect Decompression System, a minimally invasive device used to improve physical functions and reduce pain in patients with lumbar spinal stenosis (LSS).
- Stryker acquired Arrinex (US) in February 2019, a medical device company that developed ClariFix, a novel cryoablation technology for treating chronic rhinitis.
Global Pain Relief Therapy Market Scope
The pain relief therapy market is segmented on the basis products, mode of purchase, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Prescription based products
- Otc-based products.
Based on the products, the pain relief therapy market is segmented into prescription based products, OTC-based products. OTC-based products is further sub segmented into pharmaceuticals, medical devices.
Mode of purchase
- Over the counter
- Prescribed
Based on the mode of purchase, the pain relief therapy market is segmented into over-the-counter, prescribed.
Application
- Musculoskeletal disorder
- Sport medicine
- Post-operative
- Post-trauma
- Physical therapy
Based on the application, the pain relief therapy market is segmented into musculoskeletal disorder, sport medicine, post-operative, post-trauma, physical therapy.
Distribution channel
- Hospitals
- Clinics
- Ambulatory centers
- Physiotherapy centers
- Homecare settings
Based on the end-user, the pain relief therapy market is segmented into hospitals, clinics, ambulatory centers, physiotherapy centers, homecare settings.
Pain Relief Therapy Market Regional Analysis/Insights
The pain relief therapy market is analysed and market size insights and trends are provided by country, products, mode of purchase, application and end user as referenced above.
The countries covered in the pain relief therapy market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the pain relief therapy market due to the appropriate healthcare organisation, which simplifies easy access to innovative pain relief therapy. Furthermore, increasing government initiatives, combined with a well-planned repayment scenario, will drive the growth of the pain relief therapy market in the region during the forecast period. Because of the research and development funds available to create technologically innovative healthcare treatment options, Asia Pacific is expected to see significant growth in the pain relief therapy market. Furthermore, the existence of various trade agreements is expected to propel the growth of the pain relief therapy market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The pain relief therapy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for pain relief therapy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the pain relief therapy market. The data is available for historic period 2010-2020.
Competitive Landscape and Pain Relief Therapy Market Share Analysis
The pain relief therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to pain relief therapy market.
Some of the major players operating in the pain relief therapy market are
- Medtronic PLC (Ireland) ,
- Boston Scientific (US)
- Abbott (US)
- Becton Dickinson and Company (US)
- Baxter International (US)
- B. Braun Melsungen AG (Germany)
- Stryker (US)
- Smiths Medical (US)
- Moog Inc. (US)
- Avanos Medical, Inc. (US)
- Nipro Corporation (Japan)
- Atricure (US)
- Nevro Corp. (US)
- Micrel Medical Devices SA (Greece)
- InfuTronix Solutions LLC (US)
- Teleflex, Inc. (US)
- Mindray Medical International Limited (China)
- Virchow Biotech (India),
SKU-